Vascular Medicine Conference-CVC 2026

Giant Cell Arteritis (GCA) is a significant inflammatory disorder predominantly affecting large and medium-sized arteries, with a particular predilection for the temporal arteries. This condition typically presents in individuals over the age of 50. Classic symptoms include persistent headache, scalp tenderness, jaw claudication, and generalized fatigue. Of particular concern is the risk of vision loss—a complication that can develop suddenly and may be irreversible if not addressed in a timely manner. Consequently, early identification of GCA is vital to prevent lasting damage.

Diagnosis hinges on a thorough clinical assessment, supported by laboratory findings revealing elevated inflammatory markers, and often confirmed by temporal artery biopsy demonstrating characteristic giant cells and vessel wall inflammation. The cornerstone of treatment is high-dose corticosteroid therapy, which aims to rapidly suppress inflammation and avert serious complications. Ongoing follow-up care is necessary to monitor disease progression and manage the adverse effects associated with long-term steroid use. Prompt intervention is crucial in improving clinical outcomes and preserving visual function, while also controlling systemic symptoms.